Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...

In the pharmaceutical sector, continuous manufacturing (CM) has emerged as a transformative technology with the potential to revolutionize the industry. As drugmakers seek to enhance efficiency, ...

Process manufacturing is a production method in which goods are created by combining supplies, ingredients or raw materials using a predetermined formula or "recipe." The approach is frequently ...

The pharmaceutical industry stands at the precipice of a profound transformation, moving from traditional batch processing to the more efficient and agile paradigm of continuous manufacturing (CM).

Researchers at the University of Liège (BE) have designed a high-performance, open-access continuous flow process to safely produce key antibacterial drugs from bio-based furfural. The results of the ...

True CI requires moving away from firefighting and temporary fixes to permanent, sustainable change grounded in an ...

Continuous manufacturing is finally gaining traction in the pharmaceutical industry, but development of the necessary production technologies is, fittingly, a continuous process. Ultimately, the drawn ...

While moving from batch to continuous manufacturing may not be new in many other industries, it is in pharmaceutical and biotech manufacturing. According to Laura Wareham, Senior Scientist, ...

Biologics manufacturers are under increasing pressure to reduce production costs. This is a key driver for moving to continuous processing, which maximizes productivity while minimizing footprint.

The pharmaceutical industry plays a central role in Singapore’s economy and is a key pillar of the country’s high-value manufacturing strategy. Eight of the world’s top 10 biopharmaceutical companies ...